Uremic toxins activate CREB/ATF1 in endothelial cells related to chronic kidney disease

Regiane Stafim da Cunha1, Paulo Cézar Gregório1, Rayana Ariane Pereira Maciel1

  • 1Experimental Nephrology Laboratory, Basic Pathology Department, Universidade Federal do Paraná, Curitiba, PR, Brazil.

Insights

Uremic toxins like p-cresyl sulfate and indoxyl sulfate activate cAMP-responsive element-binding protein (CREB) and activating transcription factor 1 (ATF1) in endothelial cells. This activation contributes to endothelial dysfunction in chronic kidney disease (CKD).

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Uremic toxins, including p-cresyl sulfate (PCS) and indoxyl sulfate (IS), are implicated in endothelial dysfunction in chronic kidney disease (CKD).
  • The roles of cAMP-responsive element-binding protein (CREB) and activating transcription factor 1 (ATF1) in uremic endothelial dysfunction are not fully understood, despite their involvement in inflammatory pathways.

Purpose of the Study:

  • To investigate the expression, activation, and transcriptional activity of CREB and ATF1 in endothelial cells exposed to uremic toxins.
  • To determine the potential involvement of CREB/ATF1 in the endothelial dysfunction associated with CKD.

Main Methods:

  • In vitro exposure of endothelial cells to PCS, IS, and uremic serum (US).
  • Assessment of CREB and ATF1 protein levels, phosphorylation (activation), and transcriptional activity of target genes (ICAM1, PTGS2, NOX1, SLC22A6).
  • Inhibition of CREB using KG-501 to evaluate its role in toxin-induced gene expression.

Main Results:

  • PCS and IS increased ATF1 protein levels; IS also increased CREB levels.
  • PCS, IS, and US induced CREB-Ser133 and ATF1-Ser63 phosphorylation.
  • Uremic toxins upregulated inflammatory and oxidative stress genes (ICAM1, PTGS2, NOX1), with IS also affecting SLC22A6.
  • CREB inhibition partially reversed the effects of uremic toxins on target gene expression.

Conclusions:

  • CREB and ATF1 are activated by uremic toxins (PCS, IS, US) in endothelial cells.
  • Activated CREB/ATF1 signaling contributes to endothelial dysfunction in CKD by modulating inflammatory and oxidative stress pathways.
  • CREB/ATF1 represents a potential therapeutic target for mitigating endothelial dysfunction in CKD.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
137
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
96
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
133
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
70
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
118